Group 1 - The core viewpoint of the news is that Tongce Medical's stock price increased by 5.11% to 47.48 CNY per share, with a trading volume of 836 million CNY and a turnover rate of 4.01%, resulting in a total market capitalization of 21.237 billion CNY [1] - Tongce Medical Co., Ltd. is located in Hangzhou, established on August 30, 1995, and listed on October 30, 1996. The company primarily engages in medical service investment and dental medical services [1] - The revenue composition of Tongce Medical is as follows: medical services account for 92.84%, product sales 4.06%, construction engineering 2.72%, and others 0.38% [1] Group 2 - Among the top circulating shareholders of Tongce Medical, a fund under Southern Fund holds a significant position. The Southern CSI 500 ETF (510500) reduced its holdings by 106,700 shares in the third quarter, now holding 4.5641 million shares, which is 1.02% of the circulating shares [2] - The Southern CSI 500 ETF (510500) was established on February 6, 2013, with a latest scale of 144.69 billion CNY. Year-to-date returns are 15.26%, ranking 552 out of 5,551 in its category; over the past year, returns are 56.56%, ranking 1,089 out of 4,285; and since inception, returns are 190.06% [2] - The fund manager of Southern CSI 500 ETF (510500) is Luo Wenjie, who has a cumulative tenure of 12 years and 286 days, with total fund assets of 171.358 billion CNY. The best fund return during his tenure is 192.55%, while the worst is -47.6% [2]
通策医疗股价涨5.11%,南方基金旗下1只基金位居十大流通股东,持有456.41万股浮盈赚取1054.31万元